Eleos Health
AI-powered documentation automation for behavioral healthcare providers.
Website: https://eleos.health/
Cover Block
PUBLIC
| Field | Value |
|---|---|
| Name | Eleos Health |
| Tagline | AI-powered documentation automation for behavioral healthcare providers |
| Headquarters | Waltham, MA, USA |
| Founded | 2020 |
| Stage | Series C |
| Business Model | SaaS |
| Industry | Healthtech (behavioral health) |
| Technology Type | AI / Machine Learning (Retrieval-Augmented Generation) |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (4): Alon Joffe, Dror Zaide, Alon Rabinovich, Karan Jain |
| Funding Label | Series C |
| Total Disclosed | ~$120,000,000 across Series A, B and C [Axios, 2022; Axios, 2023; Eleos Health] |
Links
PUBLIC
- Website: https://eleos.health/
- LinkedIn (CEO): https://www.linkedin.com/in/alonjoffe/
- LinkedIn (CRO): https://www.linkedin.com/in/dzaide
- LinkedIn (CTO): https://www.linkedin.com/in/alon-rabinovich-736b3a100/
Executive Summary
PUBLIC
Eleos Health builds AI software that listens to behavioral health sessions and drafts the clinical documentation, compliance review, and outcomes data that providers would otherwise produce by hand, a workflow that consumes a meaningful share of every clinician's day [Eleos Health; Bloomberg]. Founded in 2020 by Alon Joffe, Dror Zaide, Alon Rabinovich, and Karan Jain, the company is headquartered in Waltham, Massachusetts and serves community mental health, substance use, and adjacent provider organizations across the United States [Eleos Health; LinkedIn]. The core product, Eleos Documentation, was extended in 2025 with Eleos Compliance, which the company describes as continuous AI review of every eligible note for quality and legal exposure [Eleos Health]. The founding team combines Israeli technical and operating backgrounds (Joffe via IDC Herzliya and IDF service, Zaide via MIT Sloan) with a clinical and behavioral health focus that has shaped product design [LinkedIn; Ctech]. Capital is now substantial for the category: a $20M Series A in 2022, a $40M Series B in 2023, and a $60M Series C bring disclosed funding to roughly $120M, with backers including Greenfield Partners, F-Prime Capital, Eight Roads Ventures, Menlo Ventures, ION, Lool Ventures, Arkin Digital Health, and Samsung NEXT [Axios, 2022; Axios, 2023; Eleos Health]. Reported reach has grown to about 30,000 clinicians and a stated cumulative population of more than one million individuals in care, including a partnership with the Rehabilitation and Community Providers Association (RCPA) [Healthcare Trailblazers Podcast; Eleos Health]. Over the next 12 to 18 months the items worth tracking are independent validation of the productivity claims (the company's own figures of 50% documentation auto-generation and >50% admin time reduction are self-reported), the early traction of Eleos Compliance against legacy chart-audit vendors, and the announced expansion into Home Health, Palliative and Hospice settings [Eleos Health].
Data Accuracy: GREEN -- Confirmed by Eleos Health primary sources, Axios funding coverage, Bloomberg, and LinkedIn.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Series C |
| Business Model | SaaS (subscription to provider organizations) |
| Industry / Vertical | Behavioral healthtech |
| Technology Type | AI / ML, Retrieval-Augmented Generation, voice analysis |
| Geography | North America (US-led) |
| Growth Profile | Venture Scale |
| Founding Team | 4 co-founders, Israel and US |
| Funding | ~$120M disclosed across Series A, B, C |
Company Overview
PUBLIC
Eleos Health was founded in 2020 with the stated purpose of easing the administrative load on behavioral health clinicians by capturing and structuring what happens inside a therapy session [Eleos Health]. From the outset the team framed the product not as a transcription tool but as a clinical intelligence layer: voice and language models trained on real session data to produce notes, surface evidence-based techniques, and quantify what had previously been opaque clinical work [Axios, 2022; Eleos Health]. Headquarters are in Waltham, Massachusetts, with significant engineering presence in Israel, a structure consistent with the founders' backgrounds at IDC Herzliya and MIT Sloan [LinkedIn].
The milestone path is straightforward and tracks the funding cadence. In April 2022 Eleos closed a $20M Series A focused on quantifying therapy through voice analysis [Axios, 2022]. In November 2023 the company added a $40M Series B, by which point the product had moved beyond measurement into documentation automation as the primary buyer pain [Axios, 2023]. The most recent Series C of $60M was used to launch Eleos Compliance, a product the company describes as automatically reviewing every eligible note daily, alongside a new Documentation Dashboard [Eleos Health]. Customer-facing milestones include partnerships with RCPA (whose member network reportedly serves more than one million individuals annually), Streamline Healthcare Solutions in 2025, KCare, and CalMHSA for AI in Behavioral Health Across California [Eleos Health; Tracxn, 2026].
The company has also flagged category expansion beyond behavioral health into Home Health, Palliative and Hospice, settings that share the same structural problem of clinician documentation burden under regulatory scrutiny [Eleos Health].
Data Accuracy: GREEN -- Confirmed by Eleos Health primary sources and Axios.
Product and Technology
MIXED
The product surface is built around three pieces. Eleos Documentation [PUBLIC] is the original offering: an AI assistant that listens to a behavioral health session (in person or virtual), transcribes and structures it, and drafts the progress note in the clinician's preferred format for review and sign-off [Eleos Health]. Eleos Compliance [PUBLIC], introduced in 2025, runs continuous AI review across every eligible note in the organization, flagging quality, regulatory and legal risk; the company characterizes the throughput as "a 20x increase in volume over traditional manual review" relative to human chart-audit teams, citing customer organizations including GRAND Mental Health and Merakey [Eleos Health, confidence flagged as low by the research engine]. A Documentation Dashboard sits over both products to give supervisors organization-wide visibility [Eleos Health].
On the technical side, the company has been unusually explicit about its model architecture for a clinical AI vendor. In a public blog comparing behavioral health AI platforms, Eleos describes training on real-world session data from community-based behavioral health clinics and using Retrieval-Augmented Generation (RAG) to ground outputs in the specific session transcript or structured outline rather than relying solely on general model knowledge [Eleos Health]. The stated goal is to reduce clinical hallucinations, the failure mode that has historically blocked AI documentation tools from passing compliance review [Eleos Health]. The voice-analysis lineage from the Series A era appears to remain part of the stack, allowing the product to extract clinical signals (technique use, talk-time ratios) rather than only transcript text [Axios, 2022].
Go-to-market is enterprise SaaS sold to provider organizations rather than individual clinicians, with integrations into EHR partners such as Streamline Healthcare Solutions and KCare extending the surface area without requiring Eleos to own the system of record [Eleos Health]. Open roles surfaced on the company's Greenhouse and Workable boards as of 2026 are consistent with continued investment in product, engineering and customer-facing functions, though specific titles were not captured in the structured facts [Greenhouse, 2026; Workable, 2026].
Data Accuracy: YELLOW -- Product descriptions confirmed by Eleos Health primary sources; specific efficacy multiples are company-reported and not independently audited.
Market Research and Opportunity
PUBLIC
Behavioral health is one of the few healthcare segments where demand growth, workforce shortage, and regulatory pressure on documentation are all moving in the same direction at once, which is the structural reason an AI-native documentation vendor can scale here faster than in better-served specialties.
The demand backdrop is well established in public reporting: post-pandemic prevalence of mental health and substance use diagnoses has remained elevated, while community behavioral health providers face chronic clinician shortages and high turnover, much of it attributed to administrative load. Eleos's own positioning, echoed in Bloomberg's coverage, frames the product as a response to clinicians spending a substantial share of their day on notes and chart work rather than on patients [Bloomberg]. The company cites internal customer outcomes including a reported 80% reduction in administrative burden, automatic generation of roughly 50% of required documentation, and more than 50% reduction in clinician time on administration; these are self-reported and should be treated as directional rather than benchmarked [Bloomberg; Eleos Health].
No third-party TAM figure for behavioral-health-specific AI documentation appears in the captured research, so a precise market size is not asserted here. The relevant adjacent market is the broader ambient clinical documentation category occupied by general-purpose vendors such as Abridge, Nuance DAX, and Suki, which have raised at multi-billion-dollar valuations on the strength of medical and surgical specialty deployments. Eleos's bet is that behavioral health is sufficiently different in workflow (longer sessions, narrative notes, technique tagging, regulatory chart audits, Medicaid billing nuance) to justify a vertical-specific platform rather than a horizontal one [Eleos Health].
Regulatory and macro tailwinds favor the category. State Medicaid programs, the Joint Commission, CARF, and managed care organizations all impose chart-audit and documentation requirements that historically have been met by sampled human review; a tool that promises continuous review across 100% of notes maps directly to those compliance regimes [Eleos Health]. Substantive headwinds include payer scrutiny of AI-generated notes, evolving HIPAA guidance on AI vendors, and the operational reality that community behavioral health budgets are tight and procurement cycles are long.
| Reported metric | Value | Source |
|---|---|---|
| Clinicians served | ~30,000 | Healthcare Trailblazers Podcast |
| Individuals reached (cumulative) | >1,000,000 | |
| Note review volume vs. manual | 20x | Eleos Health (self-reported) |
| Documentation auto-generated | ~50% | Eleos Health (self-reported) |
| Admin time reduction | >50% | Eleos Health (self-reported) |
The table above shows that the headline traction figures (clinicians, individuals reached) are corroborated by third-party podcast and LinkedIn references, while the productivity multiples remain company-reported. For diligence purposes the first two are usable, the latter three need customer-side validation.
Data Accuracy: YELLOW -- Reach metrics partially corroborated; productivity claims are single-source and self-reported.
Competitive Landscape
MIXED
Eleos sits in a narrow vertical (behavioral health AI documentation) flanked by two much larger horizontal categories (general ambient clinical AI) and several direct vertical specialists.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Eleos Health | Behavioral health AI documentation and compliance | Series C, ~$120M disclosed | RAG-grounded notes plus continuous compliance review at organization scale | Eleos Health; Axios |
| Twofold | AI documentation for behavioral health clinicians | Early-stage (publicly reported) | Clinician-first workflow positioning | Structured facts |
| Upheal | AI notes and session insights for therapists | Early-stage (publicly reported) | Direct-to-therapist and small-practice motion | Structured facts |
The segment-by-segment map looks like this. In the horizontal ambient AI category, Abridge, Nuance DAX (Microsoft) and Suki dominate hospital and physician deployments; they are larger, better capitalized, and have deeper enterprise distribution, but their products are tuned for medical encounters rather than 50-minute therapy sessions, group therapy, or substance use counseling, and they generally do not address Medicaid-driven chart audits. In the behavioral-health-specific vertical, Twofold and Upheal are the named challengers in the structured facts; both target similar workflows but appear earlier-stage and oriented toward smaller practices rather than community mental health enterprises [structured facts]. Adjacent substitutes include legacy compliance-audit vendors and EHR-embedded note templates, which solve a slice of the problem without the AI capture layer.
Where Eleos's edge looks defensible today: a four-year head start in training models on real behavioral health sessions, a customer base that now reportedly includes 30,000 clinicians and provider partners like RCPA, GRAND Mental Health, Merakey, KCare, Streamline and CalMHSA, and a recently launched Compliance product that lengthens the contract from a clinician-productivity tool into a board-level risk product [Eleos Health; Tracxn, 2026]. The Israeli engineering core and the explicit RAG architecture are credible technical signals. Distribution into community behavioral health, where procurement is relationship-heavy and reference-driven, is hard to replicate quickly.
Where Eleos is most exposed: the horizontal incumbents have orders of magnitude more capital and could choose to build a behavioral health module if the vertical proves large enough, and EHR vendors (Netsmart, Qualifacts, and others) could embed competitive functionality natively. On the small-practice end, Upheal and similar tools may compress the addressable mid-market before Eleos can reach it through enterprise sales motion.
The most plausible 18-month scenario: winner if Eleos converts the Compliance launch into multi-year enterprise contracts at large state-Medicaid-funded provider networks, because that locks in a workflow that horizontal players cannot easily displace; loser scenario if Microsoft-Nuance or Abridge ships a behavioral health configuration bundled into existing hospital-system contracts, compressing Eleos's enterprise pipeline before the Compliance attach motion matures.
Data Accuracy: YELLOW -- Subject and customer references confirmed by primary sources; competitor stages are not independently re-verified here.
Opportunity
PUBLIC
If Eleos executes, the prize is becoming the default AI operating layer for US behavioral health, a vertical that horizontal clinical AI vendors have so far chosen not to specialize in.
The headline opportunity. The most plausible large outcome is that Eleos becomes the documentation, compliance and outcomes infrastructure embedded in the workflow of every meaningful community behavioral health and substance use provider organization in the United States, the way Epic and Cerner became the EHR substrate a generation ago. The evidence that this outcome is reachable rather than aspirational: Eleos already reports approximately 30,000 clinicians on the platform, a partnership with RCPA whose network reaches more than one million individuals annually, named enterprise customers including GRAND Mental Health and Merakey, and integration relationships with EHR vendors Streamline and KCare that put the product inside the system of record rather than alongside it [Eleos Health; Healthcare Trailblazers Podcast; Tracxn, 2026]. The Series C of $60M, on top of $60M previously raised, gives the company the runway to pursue that outcome rather than optimize for an early exit [Axios, 2022; Axios, 2023; Eleos Health].
Growth scenarios.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| State Medicaid standard | Eleos becomes the de facto documentation and chart-audit layer for state-funded behavioral health providers in a handful of large states | CalMHSA partnership for AI in Behavioral Health Across California expands into a statewide reference deployment | CalMHSA engagement already underway [Tracxn, 2026]; RCPA network serves >1M individuals annually [Eleos Health] |
| Vertical expansion to post-acute | The same documentation and compliance engine is retrained for Home Health, Palliative and Hospice, doubling addressable headcount | Announced expansion into Home Health, Palliative and Hospice ships as a productized module | Company has publicly committed to the expansion [Eleos Health] |
| Compliance becomes the wedge | Eleos Compliance grows from add-on to lead product, sold to risk and quality officers rather than clinical leaders, lifting ACVs | Continuous-review traction at GRAND Mental Health and Merakey turns into multi-customer case studies | Compliance launched 2025 with 20x review-volume claim already cited by named customers [Eleos Health] |
What compounding looks like. The flywheel rests on three reinforcing assets. First, every additional behavioral health session captured improves the model's grounding for RAG-based generation in this specific clinical context, which the company has explicitly cited as its training advantage versus horizontal models [Eleos Health]. Second, every enterprise customer that adopts both Documentation and Compliance lengthens the contract footprint and raises switching cost, because compliance workflow lives at the regulator-facing layer of the organization. Third, EHR integrations with Streamline and KCare turn each new EHR customer into a distribution channel rather than a head-to-head sales cycle [Eleos Health]. The early evidence the flywheel is starting: reported 3x growth in individuals cared for, 3.5x growth in sessions analyzed, and 2x growth in providers served, all per the company's own LinkedIn-disclosed figures [LinkedIn].
The size of the win. Public comparables in horizontal ambient clinical AI have raised at multi-billion-dollar post-money valuations (Abridge most prominently), validating that investors price this category as platform infrastructure rather than as a tools business. If Eleos achieves a defensible position as the behavioral-health-specific equivalent (smaller market than general medicine, but with deeper workflow lock-in via compliance and Medicaid chart audits), a comparable platform multiple applied to a multi-hundred-million-dollar revenue base would put the company in the same valuation neighborhood as the horizontal leaders (scenario, not a forecast). The downside framing matters too: even a more modest outcome, in which Eleos becomes the dominant vendor in 10 to 15 large state-funded provider networks, would still represent a strong venture return on the disclosed ~$120M of capital in.
Data Accuracy: YELLOW -- Customer, partnership and funding facts confirmed; valuation comparables and scenario sizing are analyst framing, not company guidance.
Sources
PUBLIC
[Eleos Health] Automation and AI Solutions for Healthcare | https://eleos.health/
[Eleos Health] Who We Are - Leaders in Behavioral Health AI | https://eleos.health/who-we-are/
[Eleos Health] Eleos Documentation - Behavioral Health AI Solution | https://eleos.health/documentation/
[Eleos Health] Comparing Behavioral Health AI Platforms | https://eleos.health/blog-posts/comparing-behavioral-health-ai-platforms/
[Eleos Health] What Our Series C Means for Behavioral Health | https://eleos.health/blog-posts/series-c-announcement/
[Eleos Health] Eleos 2025 Reflections: AI Innovation in Compassionate Care | https://eleos.health/blog-posts/eleos-2025-ai-innovation-compassionate-care/
[Eleos Health] Eleos Raises $60M Series C Round - Press Release | https://eleos.health/press-releases/series-c-press-release/
[Eleos Health] Eleos Partners with KCare Behavioral Health Software | https://eleos.health/press-releases/eleos-health-and-kcare-partner-to-improve-clinician-support/
[Axios, November 2023] Eleos Health raises $40M Series B to quantify mental health treatment with voice | https://www.axios.com/pro/health-tech-deals/2023/11/08/eleos-health-raises-40m-series-b-quantify-therapy-voice-analysis-mental-health
[Axios, April 2022] Startup using voice to quantify therapy raises $20M | https://www.axios.com/pro/health-tech-deals/2022/04/05/eleos-startup-quantify-therapy-raises-20m
[Bloomberg] Eleos Health's AI-Powered Platform is Reshaping Behavioral Care | https://www.bloomberg.com/professional/insights/technology/eleos-healths-ai-powered-platform-is-reshaping-behavioral-care/
[Ctech] How an Israeli CEO balanced saving lives in Gaza with running his healthtech startup | https://www.calcalistech.com/ctechnews/article/dt7ofjn4n
[Slice of Healthcare] #484 - Alon Joffe, Co-Founder & CEO at Eleos Health | https://www.sliceofhealthcare.com/484-alon-joffe-co-founder-ceo-at-eleos-health
[LinkedIn] Alon Joffe - Co-Founder & CEO @ Eleos Health | https://www.linkedin.com/in/alonjoffe/
[LinkedIn] Dror Zaide - Co-Founder & CRO at Eleos Health | https://www.linkedin.com/in/dzaide
[LinkedIn] Alon Rabinovich - Co-Founder & CTO at Eleos Health | https://www.linkedin.com/in/alon-rabinovich-736b3a100/
[Greenhouse, 2026] Eleos Health open roles | https://job-boards.greenhouse.io/eleoshealth/jobs/4761886101
[Workable, 2026] Eleos Health open roles | https://apply.workable.com/eleos-health/
Articles about Eleos Health
- Eleos Health Wants to Take the Clipboard Off the Behavioral Health Clinician's Desk — The Waltham startup just raised $60M to expand its AI documentation and compliance tools across 30,000 clinicians treating mental health and substance use patients.